Advertisement

Topics

Oxford Molecular Group Incorporated Company Profile

02:51 EST 16th December 2018 | BioPortfolio

Oxford Molecular provides software tools and collaborative research services for identifying and optimizing drug candidates from biological targets. New automated technologies in genomics, high-throughput screening and combinatorial chemistry offer solutions for increasing the quantity and quality of pre-clinical drug candidates. Oxford Molecular helps companies to realize the benefits of these new technologies in the following areas:

Bioinformatics

Cheminformatics

Lead Optimization

Collaborative Research

Bioinformatics



Oxford Molecular is a leading supplier of software solutions for bioinformatics, including data services. Our bioinformatics products include the GCG Wisconsin Package™ and its two interfaces: SeqWeb™ for your web browser, and SeqLab® for X Windows. For the desktop, we offer OMIGA for Windows® and MacVector™ for the Macintosh. We also offer DataServe™, a convenient FTP service allowing pre-formatted downloads of public sequence databases. Finally, there is GENESEQ™ for comprehensive searching of patent sequences obtained from over 40 patent–issuing authorities worldwide.



New bioinformatics products include SeqStore™, which uses an Oracle® framework to integrate public, proprietary and in-house data across your company. Also new is OMIGA-GCG™, which enables users to search and retrieve sequence data from GCG Wisconsin Package databases and then perform sequence analysis within OMIGA’s Windows-based environment.



Cheminformatics



Oxford Molecular’s RS3 Discovery™ is an enterprise-wide research information solution using Oracle. RS3 manages the deluge of data from high-throughput screening and combinatorial chemistry synthesis. It can also assist in rapidly analyzing results and efficiently sharing verified data throughout the organization.



We also offer DIVA, an innovative visual tool for analyzing structures, properties and assay data. DIVA helps identify significant new entities from among thousands of compounds.



Oxford Molecular provides Chem-X™ for combinatorial library registration and lead generation. Its pharmacophore-based tools simplify library comparison and virtual screening.



Lead Optimization



Oxford Molecular helps scientists to discover relationships between molecular structure and activity, understand reactions and interactions between molecules, predict properties of new molecules, determine biological activity and assess toxicity—before expensive laboratory work is undertaken.



CAChe™ is a family of molecular modeling products for Macintosh and Windows desktop computers. Its award-winning user interface lets experimental chemists easily visualize molecules and reactions as well as predict and compare their chemical and physical properties.



For more sophisticated analysis, Oxford Molecular offers a suite of structure-activity programs for SGI workstations:



Tsar™ displays structures and properties in a spreadsheet form and performs a variety of statistical analyses. Tsar can also automatically substitute R-groups to define compounds.

Corina™ converts 2D structures to 3D.

Asp™ automatically aligns molecules for visual comparison.

Topkat® QSTRS provides quantitative assessment of toxicity from structure

Vamp™ performs semi-empirical quantum mechanics calculations to predict a variety of chemical and physical properties.

Collaborative Research



Oxford Molecular’s Collaborative Discovery division uses its expertise in informatics and drug design to accelerate the drug discovery process for clients in pharmaceutical and biotechnology companies. This expertise is complemented by the chemical synthesis skills of Cambridge Combinatorial and the advanced screening capabilities of Cambridge Drug Discovery. As a result, we are able to provide integrated, cost-effective solutions for target identification and validation, lead identification, and lead optimization.



Collaborative Discovery personnel have successfully managed and completed a wide range of multidisciplinary research collaborations. They bring together significant drug discovery experience in industry while also providing access to leading academic institutions through their relationships with key individuals. Our partners experience the benefits of new technologies while saving time and avoiding the cost of developing or supplementing internal resources.



Contact details



For further information, please contact Oxford Molecular:



Europe



Oxford Molecular Group PLC, Medawar Centre, Oxford Science Park, Oxford OX4 4GA, UK; tel: +44 1865 784600; fax: +44 1865 784601; web site http://www.oxmol.co.uk



US



Oxford Molecular Group, Inc., 2105 South Bascom Ave., Suite 200, Campbell, CA 95008, USA; tel: 1-408-879-6300 or 1-800-876-9994; fax: 1-408-879-6302; web site: http://www.oxmol.com

Location

2105 South Bascom Avenue Suite 200
Campbell
CA
95008
United States of America

Contact

Phone: 408 879 6300
Fax: 408 879 6302


News Articles [1542 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Paramount Recruitment: Group Leader Viral Vectors – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Group Leader Viral Vectors – Oxford . Negotiable...

Oxford BioMedica Notes the Longer-Term Analyses from Pivotal Kymriah Trials, Which Showed Durable Responses Are Maintained in Patients with Advanced Blood Cancers

Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, today notes an announcement by Novartis on the longer-term analyses of both the ELIANA an...

Scientists Identify Key Sensory Tradeoffs in Bats

NewsA new study has examined whether enhanced echolocation acoustic abilities spurred the loss of vision across a large and diverse group of bat species.Cont

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

Oxford Biodynamics Raises $12.5 Million from China's GL Capital for Biomarkers

Oxford Biodynamics PLC raised $12.5 million from GL Capital Group, a Shanghai private equity investor with a healthcare focus. OBD uses a proprietary platform, EpiSwitch™, to develop biomarkers ...

Nitric Oxide conference gets under way in Oxford

Delegates from round the world have descended on Oxford for the 10th international conference of the Nitric Oxide Society, which has got under way. This year, the NIHR oxford Biomedical Research Centr...

Oxford Gene Technology: Mike Evans. Providers of innovative genetics research and biomarker solutions to advance molecular medicine

Mike Evans, CEO of Oxford Gene Technology talks to Fintan Walton about OGT's new diagnostic techiques and innovative research into Lupus, Prostate and Colorectal cancers.

FDA clears DiaSorin Molecular's group B strep assay

The FDA has granted DiaSorin Molecular clearance to market its Simplexa GBS Direct assay for qualitative detection of group B -More- 

PubMed Articles [3655 Associated PubMed Articles listed on BioPortfolio]

Cytological and molecular aspects of the ageing sperm.

Is ageing associated with a decline in semen quality and molecular changes to human sperm?

Similar Outcomes of Two-Stage Revisions for Infection and One-Stage Revisions for Aseptic Revisions of Knee Endoprostheses.

Two-stage revision knee arthroplasty using an antibiotic-loaded spacer is the most widely performed procedure for infected knee arthroplasties. The clinical outcome of this type of surgery compared wi...

NanoShaper-VMD interface: computing and visualizing surfaces, pockets and channels in molecular systems.

NanoShaper is a program specifically aiming the construction and analysis of the molecular surface of nanoscopic systems. It uses ray-casting for parallelism and it performs analytical computations wh...

Higher-order molecular organization as a source of biological function.

Molecular interactions have widely been modelled as networks. The local wiring patterns around molecules in molecular networks are linked with their biological functions. However, networks model only ...

Acetyl Methyl Torsion in Pentan-2-One as Observed by Microwave Spectroscopy.

The rotational spectra of two conformers of pentan-2-one (also known as methyl propyl ketone) were recorded in the frequency range from 2 to 40 GHz using two molecular jet Fourier transform microwave ...

Clinical Trials [5623 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Evaluating Alternative Aftercare Models for Ex-offenders

This study is examining the relative effects of alternative aftercare models for ex-offenders who are recovering from substance abuse/addiction. The study is a longitudinal, randomized fie...

Companies [2629 Associated Companies listed on BioPortfolio]

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

Oxford BioMedica plc

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutic...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

More Information about "Oxford Molecular Group Incorporated" on BioPortfolio

We have published hundreds of Oxford Molecular Group Incorporated news stories on BioPortfolio along with dozens of Oxford Molecular Group Incorporated Clinical Trials and PubMed Articles about Oxford Molecular Group Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Molecular Group Incorporated Companies in our database. You can also find out about relevant Oxford Molecular Group Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record